XCUR

EXICURE, INC.

Healthcare · Biotechnology

$174.75 sample

+0.82 (+0.47%) 1D

Market cap

$466.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$174.75 +9.45% 3M daily closessample

180.77159.66

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: Chief Executive Officer
Oct 06INSInsider sell: Director
Sep 28INSInsider buy: Director
Sep 17SEC10-Q filed
Sep 14SECForm 144 filed
Sep 08INSInsider sell: Director
Sep 02SECForm 144 filed
Aug 26INSInsider sell: General Counsel

Sign up to see the real XCUR record →

Company facts

SEC EDGAR registration

Name: EXICURE, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +56sample, -100 to +100
Reporting currency: USD

Who is positioning in XCUR

sample

Insiders: 24 insider transactions over 90 days, net selling, $64.2M
Congress: 5 members traded over 90 days
Institutions · 13F: 38 funds hold $10.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.6B +18.3% y/y

Q4 2024Q3 2026

Inventory$13.3B +12.6% y/y

Q4 2024Q3 2026

Accounts receivable$10.0B +19.4% y/y

Q4 2024Q3 2026

Total debt$26.8B +20.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $242.8B -13.5% 3M
Sample peer B: $332.1B -4.3% 3M
Sample peer C: $266.9B +6.6% 3M
Sample peer D: $454.7B -0.3% 3M
Sample peer E: $325.7B +5.8% 3M